A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
for
Pulmonary Arterial Hypertension
Location: Boston MA, Charleston SC, Hamilton, Scottsdale AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07218029
Phase3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Location: Greenacres City FL, Loxahatchee Groves FL, Miami FL,
Sponsor: Pfizer
Sex: All
Age: 35 - 70+
Code: NCT07363694
Phase2, Phase3, Recruiting
Active & Responsive
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
for
Asthma Control, Pulmonary Function, Quality of Life, Stress,
Location: Plano TX, Arlington TX
Sponsor: The University of Texas at Arlington
Sex: All
Age: 5+
Code: NCT07196436
Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
for
Lung Transplant, Pulmonary Hypertension
Location: Jacksonville FL
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70+
Code: NCT06770023
Phase1, Recruiting
Active & Responsive
Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
for
Chronic Obstructive Pulmonary Disease
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 40 - 70+
Code: NCT05061368
Phase2, Recruiting
Active & Responsive
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
for
Emphysema, Pulmonary, Emphysema or COPD
Location: Boston MA, Hartford CT, Philadelphia PA,
Sponsor: Pulmonx Corporation
Sex: All
Age: 40 - 70+
Code: NCT06035120
Recruiting
Active & Responsive
Feasibility Trial for a Right Ventricular Failure Platform Trial
for
Pulmonary Hypertension, Right Ventricular Dysfunction,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18+
Code: NCT06570473
Phase2, Recruiting
Active & Responsive
Spironolactone for Pulmonary Arterial Hypertension
for
Pulmonary Arterial Hypertension
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 18 - 70+
Code: NCT01712620
Phase2, Recruiting
Active & Responsive
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
for
Pulmonary Disease, Pulmonary Hypertension
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 18 - 70+
Code: NCT01730092
Recruiting
Active & Responsive
129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: London
Sponsor: Western University, Canada
Sex: All
Age: 50 - 70+
Code: NCT07192016
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension
Location: Philadelphia PA, Rochester NY, Anderson SC,
Sponsor: Insmed Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07481981
Phase3, Recruiting
Active & Responsive
18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
for
Tuberculosis, Pulmonary
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 18+
Code: NCT07077213
Recruiting
Active & Responsive
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
for
COPD, Chronic Obstructive Pulmonary Disease
Location: Philadelphia PA, DuBois PA, Jacksonville FL,